Epithelioid sarcoma: New insights based on an extended immunohistochemical analysis

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 9, 2003, Pages 1161-1168

  Laskin, William B ^a,c   Miettinen, Markku ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CALRETININ; CD34 ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; KERATIN; KERATIN ANTIBODY; PLAKOGLOBIN; PROTEIN P63; VIMENTIN;

ADOLESCENT; ADULT; CHILD; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; EPITHELIOID SARCOMA; FEMALE; HISTOGENESIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MESENCHYMOMA; PHENOTYPE;

ADOLESCENT; ADULT; AGED; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CHILD; CHILD, PRESCHOOL; CYTOSKELETAL PROTEINS; DESMOPLAKINS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GAMMA CATENIN; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-14; KERATINS; MALE; NEPRILYSIN; PROTO-ONCOGENE PROTEINS C-KIT; SARCOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 0041333180     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (55)

1. Laskowsky J. Sarcoma aponeuroticum. Nowotwory. 1961;11:61-67.
2. Dabska M, Koszarowski T. Clinical and pathologic study of aponeurotic (epithelioid) sarcoma. Pathol Ann. 1982;17:129-153.
3. Enzinger FM. Epithelioid sarcoma: a sarcoma simulating a granuloma or a carcinoma. Cancer. 1970;26:1029-1041.
4. Chase DR, Enzinger FM. Epitheliold sarcoma: diagnosis, prognostic indicators, and treatment. Am J Surg Pathol. 1985;9:241-263.
5. Bos GD, Pritchard DJ, Reiman HM, et al. Epitheliold sarcoma: an analysis of fifty-one cases. J Bone Joint Surg Am. 1988;70:862-870.
6. Evans HL, Baer SC. Epitheliold sarcoma: a clinicopathologic and prognostic study of 25 cases. Semin Diagn Pathol. 1993;10:286-291.
7. Halling AC, Wollen PC, Pritchard DJ, Vlasak R, Nascimento AG. Epithelioid sarcoma: a clinicopathologic review of 55 cases. Mayo Clin Proc. 1996;71:636-642.
8. Miettinen M, Fanburg-Smith JC, Virolainen M, Shmookler BM, Fetsch JF. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol. 1999;30:934-942.
9. Santiago H, Feinerman LK, Lattes R. Epithelioid sarcoma, a clinical and pathologic study of nine cases. Hum Pathol 1972;3:133-147.
10. Guillou L, Wadden C, Coindre J-M, Krausz T, Fletcher CDM. "Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features: clinicopathological, immunohistochemical and ultrastructural study of a series. Am J Surg Pathol. 1997;21:130-146.
11. Mirra JM, Kessler S, Bhuta S, Eckardt J. The fibroma-like variant of epithelioid sarcoma: a fibrohistiocytic/myoid cell lesion often confused with benign and malignant spindle cell tumors. Cancer. 1992;69:1382-1395.
12. Von Hochstetter AR, Meyer VE, Grant JW, Honegger HP, Schreiber A. Epithelioid sarcoma mimicking angiosarcoma: the value of immunohistochemistry in the differential diagnosis. Virchows Arch A Pathol Anat Histopathol. 1991;418:271-278.
13. Chase DR, Enzinger FM, Weiss SW, Langloss JM. Keratin in epithelioid sarcoma: an immunohistochemical study. Am J Surg Pathol. 1984;8:435-441.
14. Schmidt D, Harms D. Epithelioid sarcoma in children and adolescents: an immunohistochemical study. Virchows Arch A Pathol Anat Histopathol. 1987;410:423-431.
15. Fisher C. Epithelioid sarcoma: the spectrum of ultrastructural differentiation in seven immunohistochemically defined cases. Hum Pathol. 1988;19:265-275.
16. Persson S, Kindblom LG, Angervall L. Epithelioid sarcoma: an electron-microscopic and immunohistochemical study. Appl Pathol. 1988;6:1-16.
17. Mukai M, Torikata C, Iri H, et al. Cellular differentiation of epithelioid sarcoma: an electron microscopic, enzyme histochemical, and immunohistochemical study. Am J Pathol. 1985;119:44-56.
18. Daimaru Y, Hashimoto H, Tsuneyoshi M, Enjoji M. Epithelial profile of epithelioid sarcoma: an immunohistochemical analysis of eight cases. Cancer. 1987;59:131-141.
19. Manivel JC, Wick MR, Dehner LP, Sibley RK. Epithelioid sarcoma: an immunohistochemical study. Am J Clin Pathol. 1987;87:319-326.
20. Meis JM, Mackay B, Ordonez NG. Epithelioid sarcoma: an immunohistochemical and ultrastructural study. Surg Pathol. 1988;1:13-31.
21. Wick MR, Manivel JC. Epithelioid sarcoma and isolated necrobiotic granuloma: a comparative immunochemical study. J Cutan Pathol. 1986;13:253-260.
22. Ishida T, Oka T, Matsushita H, Machinami R. Epithelioid sarcoma: an electron-microscopic, immunohistochemical and DNA flow cytometric analysis. Virchows Arch A Pathol Anat Histopathol. 1992;421:401-408.
23. Gerharz CD, Moll R, Meister P, Knuth A, Gabbert H. Cytoskeletal heterogeneity of an epithelioid sarcoma with expression of vimentin, cytokeratins, and neurofilaments. Am J Surg Pathol. 1990;14:274-283.
24. Hazelbag HM, Mooi WJ, Fleuren GJ, Hogendoorn PCW. Chain-specific keratin profile of epithelioid soft-tissue sarcoma: an immunohistochemical study on synovial sarcoma and epithelioid sarcoma. Appl Immunohistochem. 1996;4:176-183.
25. Shiratsuchi H, Oshiro Y, Saito T, et al. Cytokeratin subunits of inclusion bodies in rhabdoid cells: immunohistochemical and clinicopathological study of malignant rhabdoid tumor and epithelioid sarcoma. IntJ Surg Pathol. 2001;9:37-48.
26. Traweek ST, Kandalaft PL, Mehta P, Battifora H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol. 1991;96:25-31.
27. Arber DA, Kandalaft PL, Mehta P, Battifora H. Vimentin-negative epithelioid sarcoma: the value of an immunohistochemical panel that includes CD34. Am J Surg Pathol. 1993;17:302-307.
28. Quezado M, Middleton LP, Merino MJ. Epithelioid sarcomas: prognostic factors and immunohistochemical profile. Mod Pathol. 1996;9:12A.
29. Smith MEF, Brown JI, Fisher C. Epithelioid sarcoma: presence of vascular-endothelial cadherin and lack of epithelial cadherin. Histopathology. 1998;33:425-431.
30. Laskin WB, Miettinen M. Epithelial-type and neural-type cadherin expression in malignant noncarcinomatous neoplasms with epithelioid features that involve the soft tissues. Arch Pathol Lab Med. 2002;126:425-431.
31. Saito T, Oda Y, Itakura E, et al. Expression of intercellular adhesion molecules in epithelioid sarcoma and malignant rhabdoid tumor. Pathol Int. 2001;51:532-542.
32. Kuhnen C, Herter P, Muller O, et al. Beta-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas. Mod Pathol. 2000;13:1005-1013.
33. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40:403-439.
34. Cooper D, Schermer A, Sun TT. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations. Lab Invest. 1985;52:243-256.
35. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13:962-972.
36. Chu PG, Lydia MH, Weiss LM. Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours. Histopathology. 2001;39:9-16.
37. Clover J, Oates J, Edwards C. Anti-cytokeratin 5/6; a positive marker for epithelioid mesothelioma. Histopathology. 1997;31:140-143.
38. Ordonez NG. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol. 1998;22:1215-1221.
39. Lin L, Montgomery E, Bergfeld WF, Sigel JE, Fisher C, Goldblum JR. The utility of cytokeratin 5/6 in distinguishing superficial epithelioid sarcoma from cutaneous spindled squamous cell carcinoma. Mod Pathol. 2002;15:101A.
40. Aberle H, Schwartz H, Kemler R. Cadherin-catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem. 1996;15:514-523.
41. Barker N, Clevers H, Catenins, Wnt signaling and cancer. Bioessays. 2000;22:961-965.
42. Dei Tos AP, Doglioni C. Calretinin: a novel tool for diagnostic immunohistochemistry. Adv Anat Pathol. 1998;5:61-66.
43. Miettinen M, Limon J, Niezabitowski A, Lasota J. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma. Am J Surg Pathol. 2001;25:610-617.
44. Doglioni C, Dei Tos AP, Laurino L, et al. Calretinin; a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol. 1996;20:1037-1046.
45. Kindblom L-G, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cell of Cajal. Am J Pathol. 1998;152:1259-1269.
46. Reis-Filho JS, Schmitt FC. Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker. Adv Anat Pathol. 2002;9:280-289.
47. Parsa R, Yang A, McKeon F, Green H. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol. 1999;113:1099-1105.
48. Simon B, Podolsky DK, Moldenhauer G, Isselbacher KJ, Gattoni-Celli S, Brand SJ. Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein. Proc Natl Acad Sci U S A. 1990;87:2755-2759.
49. Momburg F, Moldenhauer G, Hammerling GJ, Moller P. Immunohistochemical study of the expression of Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res. 1987;47:2883-2891.
50. Chang K, Pai LH, Batra J, Pastan I, Willingham MC. Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 that is present on ovarian cancers and normal mesothelium. Cancer Res. 1992;52:181-186.
51. Chang K, Pai LH, Pass H, et al. Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma. Am J Surg Pathol. 1992;16:259-268.
52. Argani P, Iacobuzio-Donahue C, Ryu B, et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res. 2001;7:3862-3868.
53. Ordonez NG. Value of mesothelin immunostaining in the diagnosis of mesothelioma. Mod Pathol. 2003;16:192-197.
54. Chu P, Arber DA. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol. 2000;113:374-382.
55. Kanitakis J, Bourchany D, Claudy A. Expression of the CD10 antigen (neutral endopeptidase) by mesenchymal tumors of the skin. Anticancer Res. 2000;20:3539-3544.